Cell-based Screening and Validation of Human Novel Gene TMEM9B Activated Nuclear Factor Κb Signaling Pathway*

Liu Yu-Ming,Peng Zhi,Deng Wei-Wei,Shi Tai-Ping,Ma Da-Long

DOI: https://doi.org/10.3724/sp.j.1206.2009.00256

2009-01-01

Abstract:Nuclear factor kappa B (NF-kappa B) is an important cellular transcription factor. The important role of NF-kappa B-mediated cell signal transduction pathway in apoptosis is a hot topic at home and abroad. In order to discover new regulators In NF-kappa B signaling pathway, a high-throughput cell-based screening model based on dual luciferase reporters system was established, a number of genes that can activate NF-kappa B signal pathway were obtained by screening of 439 novel function genes. Among them, TMEM9B can obviously activate NF-kappa B signaling pathway. Further experiments showed that TMEM9B activated NF-kappa B signaling pathway in a dose-dependent pattern. Western blotting and EMSA experiments confirmed that TMEM9B can promote the degradation of I kappa B alpha (a cytoplasm inhibitor of NF-kappa B), and cause NF-kappa B shift from the cytoplasm to nucleus. At the same time, flow cytometry result demonstrated TMEM9B can induce apoptosis in HEK293T and HeLa cells. In short, a stable and effective screening system for NF-kappa B has been established, through which TMEM9B was identified to be able to significantly activate NF-kappa B signal transduction pathway and thus cause cells apoptosis.